{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:04:28Z","timestamp":1792717468424,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T00:00:00Z","timestamp":1344470400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"DOI":"10.1038\/cddis.2012.100","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T10:07:06Z","timestamp":1344506826000},"page":"e362-e362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Anti-apoptotic gene Bcl2 is required for stapes development and hearing"],"prefix":"10.1038","volume":"3","author":[{"given":"M R","family":"Carpinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A K","family":"Wise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B D","family":"Arhatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bouillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S S M","family":"Manji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M G","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A A","family":"Cooray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Burt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,9]]},"reference":[{"key":"BFcddis2012100_CR1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2174\/138161208783378789","volume":"14","author":"C Penaloza","year":"2008","unstructured":"Penaloza C, Orlanski S, Ye Y, Entezari-Zaher T, Javdan M, Zakeri Z . Cell death in mammalian development. Curr Pharm Des 2008; 14: 184\u2013196.","journal-title":"Curr Pharm Des"},{"key":"BFcddis2012100_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrm2308","volume":"9","author":"RJ Youle","year":"2008","unstructured":"Youle RJ, Strasser A . The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9: 47\u201359.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcddis2012100_CR3","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1073\/pnas.91.9.3700","volume":"91","author":"K Nakayama","year":"1994","unstructured":"Nakayama K, Negishi I, Kuida K, Sawa H, Loh DY . Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA 1994; 91: 3700\u20133704.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2012100_CR4","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1126\/science.286.5445.1735","volume":"286","author":"P Bouillet","year":"1999","unstructured":"Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999; 286: 1735\u20131738.","journal-title":"Science"},{"key":"BFcddis2012100_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1534-5807(01)00083-1","volume":"1","author":"P Bouillet","year":"2001","unstructured":"Bouillet P, Cory S, Zhang LC, Strasser A, Adams JM . Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev Cell 2001; 1: 645\u2013653.","journal-title":"Dev Cell"},{"key":"BFcddis2012100_CR6","first-page":"743","volume":"142","author":"DP LeBrun","year":"1993","unstructured":"LeBrun DP, Warnke RA, Cleary ML . Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 1993; 142: 743\u2013753.","journal-title":"Am J Pathol"},{"key":"BFcddis2012100_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrg2309","volume":"9","author":"SD Brown","year":"2008","unstructured":"Brown SD, Hardisty-Hughes RE, Mburu P . Quiet as a mouse: dissecting the molecular and genetic basis of hearing. Nat Rev Genet 2008; 9: 277\u2013290.","journal-title":"Nat Rev Genet"},{"key":"BFcddis2012100_CR8","doi-asserted-by":"publisher","first-page":"6961","DOI":"10.1073\/pnas.88.16.6961","volume":"88","author":"DM Hockenbery","year":"1991","unstructured":"Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ . BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A 1991; 88: 6961\u20136965.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFcddis2012100_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/cne.21886","volume":"512","author":"JB Fallon","year":"2009","unstructured":"Fallon JB, Irvine DR, Shepherd RK . Cochlear implant use following neonatal deafness influences the cochleotopic organization of the primary auditory cortex in cats. J Comp Neurol 2009; 512: 101\u2013114.","journal-title":"J Comp Neurol"},{"key":"BFcddis2012100_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0070-2153(03)57003-X","volume":"57","author":"M Mallo","year":"2003","unstructured":"Mallo M . Formation of the outer and middle ear, molecular mechanisms. Curr Top Dev Biol 2003; 57: 85\u2013113.","journal-title":"Curr Top Dev Biol"},{"key":"BFcddis2012100_CR11","first-page":"201","volume":"40","author":"Y Masuda","year":"1986","unstructured":"Masuda Y, Honjo H, Naito M, Ogura Y . Normal development of the middle ear in the mouse: a light microscopic study of serial sections. Acta Med Okayama 1986; 40: 201\u2013207.","journal-title":"Acta Med Okayama"},{"key":"BFcddis2012100_CR12","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrn1221","volume":"4","author":"F Santagati","year":"2003","unstructured":"Santagati F, Rijli FM . Cranial neural crest and the building of the vertebrate head. Nat Rev Neurosci 2003; 4: 806\u2013818.","journal-title":"Nat Rev Neurosci"},{"key":"BFcddis2012100_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0046-8177(74)80021-3","volume":"5","author":"RP Bolane","year":"1974","unstructured":"Bolane RP . The neurocristopathies: a unifying concept of disease arising in neural crest maldevelopment. Hum Path 1974; 5: 409\u2013429.","journal-title":"Hum Path"},{"key":"BFcddis2012100_CR14","doi-asserted-by":"publisher","first-page":"36659","DOI":"10.1074\/jbc.M109.016915","volume":"284","author":"Y Nagase","year":"2009","unstructured":"Nagase Y, Iwasawa M, Akiyama T, Kadono Y, Nakamura M, Oshima Y et al. Anti-apoptotic molecule Bcl-2 regulates the differentiation, activation, and survival of both osteoblasts and osteoclasts. J Biol Chem 2009; 284: 36659\u201336669.","journal-title":"J Biol Chem"},{"key":"BFcddis2012100_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1359\/jbmr.071211","volume":"23","author":"J Yamashita","year":"2008","unstructured":"Yamashita J, Datta NS, Chun YH, Yang DY, Carey AA, Kreider JM et al. Role of Bcl2 in osteoclastogenesis and PTH anabolic actions in bone. J Bone Miner Res 2008; 23: 621\u2013632.","journal-title":"J Bone Miner Res"},{"key":"BFcddis2012100_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0092-8674(02)00762-6","volume":"109","author":"GG McGill","year":"2002","unstructured":"McGill GG, Horstmann M, Widlund HR, Du J, Motyckova G, Nishimura EK et al. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 2002; 109: 707\u2013718.","journal-title":"Cell"},{"key":"BFcddis2012100_CR17","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.ajpath.2010.11.063","volume":"178","author":"S Kanzaki","year":"2011","unstructured":"Kanzaki S, Takada Y, Niida S, Takeda Y, Udagawa N, Ogawa K et al. Impaired vibration of auditory ossicles in osteopetrotic mice. Am J Pathol 2011; 178: 1270\u20131278.","journal-title":"Am J Pathol"},{"key":"BFcddis2012100_CR18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.bone.2006.01.155","volume":"39","author":"S Kanzaki","year":"2006","unstructured":"Kanzaki S, Ito M, Takada Y, Ogawa K, Matsuo K . Resorption of auditory ossicles and hearing loss in mice lacking osteoprotegerin. Bone 2006; 39: 414\u2013419.","journal-title":"Bone"},{"key":"BFcddis2012100_CR19","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/hmg\/ddm356","volume":"17","author":"CH Hwang","year":"2008","unstructured":"Hwang CH, Wu DK . Noggin heterozygous mice: an animal model for congenital conductive hearing loss in humans. Hum Mol Genet 2008; 17: 844\u2013853.","journal-title":"Hum Mol Genet"},{"key":"BFcddis2012100_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.heares.2009.10.002","volume":"263","author":"Z Qin","year":"2010","unstructured":"Qin Z, Wood M, Rosowski JJ . Measurement of conductive hearing loss in mice. Hear Res 2010; 263: 93\u2013103.","journal-title":"Hear Res"},{"key":"BFcddis2012100_CR21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0030-6665(20)33024-3","volume":"5","author":"DF Austin","year":"1972","unstructured":"Austin DF . Ossicular reconstruction. Otolaryngol Clin North Am 1972; 5: 145\u2013160.","journal-title":"Otolaryngol Clin North Am"},{"key":"BFcddis2012100_CR22","first-page":"81","volume":"20","author":"KE Heiland","year":"1999","unstructured":"Heiland KE, Goode RL, Asai M, Huber AM . A human temporal bone study of stapes footplate movement. Am J Otol 1999; 20: 81\u201386.","journal-title":"Am J Otol"},{"key":"BFcddis2012100_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/00016480802587846","volume":"129","author":"K Park","year":"2009","unstructured":"Park K, Choung YH . Isolated congenital ossicular anomalies. Acta Otolaryngol 2009; 129: 419\u2013422.","journal-title":"Acta Otolaryngol"},{"key":"BFcddis2012100_CR24","doi-asserted-by":"publisher","first-page":"6164","DOI":"10.1073\/pnas.0401471101","volume":"101","author":"A Egle","year":"2004","unstructured":"Egle A, Harris AW, Bouillet P, Cory S . Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc Natl Acad Sci USA 2004; 101: 6164\u20136169.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2012100_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.heares.2006.12.004","volume":"225","author":"A Coco","year":"2007","unstructured":"Coco A, Epp SB, Fallon JB, Xu J, Millard RE, Shepherd RK . Does cochlear implantation and electrical stimulation affect residual hair cells and spiral ganglion neurons? Hear Res 2007; 225: 60\u201370.","journal-title":"Hear Res"}],"container-title":["Cell Death & Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cddis2012100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cddis2012100","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2012100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:42:07Z","timestamp":1672962127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2012100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,9]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2012,8]]}},"alternative-id":["BFcddis2012100"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2012.100","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,9]]},"assertion":[{"value":"13 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}